Glaxosmithkline Pharma standalone net profit declines 25.35% in the September 2015 quarter

Sales decline 6.37% to Rs 691.90 crore

Net profit of Glaxosmithkline Pharma declined 25.35% to Rs 96.05 crore in the quarter ended September 2015 as against Rs 128.67 crore during the previous quarter ended September 2014. Sales declined 6.37% to Rs 691.90 crore in the quarter ended September 2015 as against Rs 738.98 crore during the previous quarter ended September 2014. ParticularsQuarter EndedSep. 2015Sep. 2014% Var.Sales691.90738.98 -6 OPM %18.6322.32 -PBDT160.21200.64 -20 PBT154.88195.15 -21 NP96.05128.67 -25

Powered by Capital Market - Live News